Bile and Liver Therapy
Bile and Liver Therapy Companies (9)
Bile and Liver Therapy Products (27)
-
Product 69. DUVITA (L-arginine HCl 1000mg/8 ml)
Composition: L-arginine HCl 1000mg/8 ml
Dosage Form: Oral solution
Indication:
Duvita is used in the following cases:- Maintenance therapy of hypermonia in patients with carbamylphosphate synthetase deficiency, or carbamyl transferase ornithin de...
-
Product EPAVIN
Epavin is a liquid dietary supplement formulated with a blend of plant extracts designed to support normal liver function and promote detoxification.
It combines botanical ingredients traditionally used for liver health, such as dandelion, milk thistle, artichoke, and desmodium, which work toget...
-
Product Milk Thistle + Reishi Forte
This product is designed for internal cleansing of the organism. It combines the effects of the popular milk thistle, which contributes to the protection and cleansing of the liver, and the rare reishi mushroom, which is a source of valuable beta-glucans, contributing to improving the body’s defenses and s...
-
Product 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid-(Bempedoic acid tech grade)
End Use - Bempedoic Acid
Documents Available
-
Product Compound Glycyrrhizin Tablets/Capsules/Injections
Compound Glycyrrhizin Tablets/Capsules: Chronic hepatitis, hepatic dysfunction.
Eczema, dermatitis, and dalopecia areata.
Compound Glycyrrhizin Injections:
Chronic hepatitis, hepatic dysfunction.
Eczema, dermatitis, and urticaria.
-
Product LiverMax Duo
LIVERMAX DUO support liver health in general population and menopausal women for: ● Prevention and treatment of non-alcoholic fatty liver disease (NAFLD).
● Prevention of progression to non-alcoholic steatohepatitis (NASH).
● Chronic inflammatory liver disease (due to hepatitis B and...
-
Product 98. Uformat 5ml (Urosodeoxycholic acid - Oral suspension)
Indication:
Indicated in the treatment of primary biliary cholangitis (PBC) and for the dissolution of radiolucent gallstones in patients with a functioning gall bladder
Paediatric population
Hepatobiliary disorders associated with cystic fibrosis ...
-
Product 2,2,14,14-tetramethyl-8-oxopentadecanedioic acid
End Use - Bempedoic Acid
Documents Available
-
Product Tert-butyl -2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxoprop-1-en-1-yl)phenoxy)-2-methylpropanoate
End Use - Elafibranor
Under Development
-
Product Tert-butyl (E)-2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxoprop-1-en-1-yl)phenoxy)-2-methylpropanoate
End Use - Elafibranor
Under Development
-
Product 6-(4-Amino-2,6-dichlorophenoxy)-4-isopropylpyridazin-3(2H)-one
End Use - Resmetirom
Under Development
-
Product Ethyl 4-cyano-4-(2-(3,5-dichloro-4-((5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yl)oxy)phenyl)hydrazinyl)-3-oxobutanoate
End Use - Resmetirom
Under Development
Upcoming Events
-
CPHI & PMEC China 2026
Shanghai New International Expo Center
16 Jun 2026 - 18 Jun 2026 -
CPHI South East Asia 2026
QSNCC, Bangkok, Thailand
08 Jul 2026 - 10 Jul 2026 -
CPHI Korea 2026
COEX, Seoul, Korea
25 Aug 2026 - 27 Aug 2026
%20(1).png)
%20(1).png)
.png)
%20(1).png)
.png)
%20(1).png)
.png)
.png)
